Pelican Life Sciences Secures $100M in VC Cash; Closes First Acquisition, Plans More | GenomeWeb

NEW YORK, April 25 (GenomeWeb News) - Nascent reagent shop Pelican Life Sciences has raised $100 million in private equity for acquisitions and development, the company said yesterday.

 

The company also said that it has completed its first acquisition of PML Microbiologicals, which it originally announced in December.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.